C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer

Xiao‐Zheng Liu, Anastasiia Rulina, Man Hung Choi, Line Pedersen, Johanna Lepland, Sina T. Takle, Noëlly Madeleine, Stacey D’mello Peters, Cara E Wogsland, Sturla Magnus Grøndal, James B. Lorens, Hani Goodarzi, Per Eystein Lønning, Stian Knappskog, Anders Molven, Nils HalbergNature Communications 2022 · DOI

Abstract

Epidemiological studies have established a positive association between obesity and the incidence of postmenopausal breast cancer. Moreover, it is known that obesity promotes stem cell-like properties of breast cancer cells. However, the cancer cell-autonomous mechanisms underlying this correlation are not well defined. Here we demonstrate that obesity-associated tumor formation is driven by cellular adaptation rather than expansion of pre-existing clones within the cancer cell population. While there is no correlation with specific mutations, cellular adaptation to obesity is governed by palmitic acid (PA) and leads to enhanced tumor formation capacity of breast cancer cells. This process is governed epigenetically through increased chromatin occupancy of the transcription factor CCAAT/enhancer-binding protein beta (C/EBPB). Obesity-induced epigenetic activation of C/EBPB regulates cancer stem-like properties by modulating the expression of key downstream regulators including CLDN1 and LCN2. Collectively, our findings demonstrate that obesity drives cellular adaptation to PA drives tumor initiation in the obese setting through activation of a C/EBPB dependent transcriptional network.

Introduction

The link between obesity and increased breast cancer risk, particularly in postmenopausal women, is well-documented. Obesity creates a systemic environment that fosters aggressive tumor behavior and poorer clinical outcomes. A central feature of this environment is the promotion of "stemness"—the ability of cancer cells to self-renew and initiate new tumors. However, a fundamental question remains: does obesity act as a Darwinian filter, selecting for rare, aggressive clones already present in the tumor (selection), or does it induce a widespread change in the cancer cell population (adaptation)?

Methodology

To investigate these mechanisms, researchers utilized a multi-faceted approach:

  • In Vivo Modeling: Diet-Induced Obesity (DIO) mouse models compared High-Fat Diet (HFD) and regular chow groups. Limiting dilution assays were used to calculate Cancer Stem Cell (CSC) frequencies.
  • Clonal Tracking: ClonTracer DNA barcoding was employed to monitor the fate of thousands of individual cell lineages, distinguishing between selective expansion and population-wide adaptation.
  • Metabolic Stress Simulation: Breast cancer cell lines were exposed to long-term Palmitic Acid (PA) treatment to mimic the chronic metabolic stress of an obese environment.
  • Genomic Profiling: ATAC-seq and Cut&Run were used to map chromatin accessibility and transcription factor binding (specifically C/EBPB).
  • Clinical Correlation: Tissue microarrays from 115 postmenopausal patients were analyzed to correlate BMI with clinical outcomes and stemness markers.

Key Findings

Adaptation Over Selection

Clonal barcoding experiments revealed that the clonal distribution remained remarkably similar between lean and obese mouse models. This critical finding indicates that the increased tumor-initiating capacity observed in obesity is not the result of a few "super-clones" outcompeting others. Instead, the entire cancer cell population undergoes a collective adaptation to the metabolic environment.

Palmitic Acid and the C/EBPB Master Regulator

Palmitic acid (PA), a saturated fat prevalent in high-fat diets, was identified as the primary metabolic trigger. Chronic exposure to PA induces significant epigenetic remodeling. Specifically, the transcription factor C/EBPB (CCAAT/enhancer-binding protein beta) shows increased occupancy at genomic sites that regulate stemness. This "rewiring" shifts the cancer cells toward a state resembling fetal mammary stem cells, effectively "rejuvenating" their ability to initiate tumors.

Clinical Impact and Stemness Markers

The study found that in postmenopausal patients with hormone receptor-negative (ER-/PR-) breast cancer, a BMI > 25 was associated with a nearly three-fold increase in the risk of disease-specific death (HR: 2.94).

Figure 1: Disease-specific survival in postmenopausal ER-/PR- breast cancer patients stratified by BMI.

Tumors from these patients also exhibited higher levels of stemness markers, such as CD133 and Axl. Functional assays confirmed that obesity resulted in a 6–10-fold enrichment in cancer stem cell frequencies in mouse models.

Figure 2: Obesity-associated changes in tumor-initiating capacity and clinical markers. (a) CSC frequency in mouse models. (c-d) Correlation of BMI with CD133 and Axl markers. (f) Tumorsphere formation.

Conclusion

This research clarifies that obesity-driven breast cancer progression is a process of cellular adaptation to metabolic stress, specifically palmitic acid. By identifying the C/EBPB-CLDN1/LCN2 axis as the master regulator of this transition, the study opens new avenues for targeted therapies. Future interventions might focus on reversing these epigenetic adaptations to improve outcomes for obese patients with aggressive breast cancer subtypes.

Summary updated

Abstract

Epidemiological studies have established a positive association between obesity and the incidence of postmenopausal breast cancer. Moreover, it is known that obesity promotes stem cell-like properties of breast cancer cells. However, the cancer cell-autonomous mechanisms underlying this correlation are not well defined. Here we demonstrate that obesity-associated tumor formation is driven by cellular adaptation rather than expansion of pre-existing clones within the cancer cell population. While there is no correlation with specific mutations, cellular adaptation to obesity is governed by palmitic acid (PA) and leads to enhanced tumor formation capacity of breast cancer cells. This process is governed epigenetically through increased chromatin occupancy of the transcription factor CCAAT/enhancer-binding protein beta (C/EBPB). Obesity-induced epigenetic activation of C/EBPB regulates cancer stem-like properties by modulating the expression of key downstream regulators including CLDN1 and LCN2. Collectively, our findings demonstrate that obesity drives cellular adaptation to PA drives tumor initiation in the obese setting through activation of a C/EBPB dependent transcriptional network.
BibTeX
@inproceedings{liu2022c,
  author = {Xiao‐Zheng Liu and Anastasiia Rulina and Man Hung Choi and Line Pedersen and Johanna Lepland and Sina T. Takle and Noëlly Madeleine and Stacey D’mello Peters and Cara E Wogsland and Sturla Magnus Grøndal and James B. Lorens and Hani Goodarzi and Per Eystein Lønning and Stian Knappskog and Anders Molven and Nils Halberg},
  title = {{C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer}},
  booktitle = {Nature Communications},
  year = {2022},
  doi = {10.1038/s41467-021-27734-2},
}
Figure